Teva Pharmaceutical Industries
TEVA
#554
Rank
A$63.79 B
Marketcap
A$54.70
Share price
-0.54%
Change (1 day)
91.01%
Change (1 year)

P/S ratio for Teva Pharmaceutical Industries (TEVA)

P/S ratio as of September 2026 (TTM): 2.62

According to Teva Pharmaceutical Industries's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.52. At the end of 2026 the company had a P/S ratio of 1.93.

P/S ratio history for Teva Pharmaceutical Industries from 2001 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20261.93-6.22%
20252.0631.94%
20241.56108.57%
20230.747710.16%
20220.678721.97%
20210.5564-10.99%
20200.6251-4.94%
20190.6576-26.92%
20180.89984.81%
20170.8585-48.89%
20161.68-44.21%
20153.0125.69%
20142.4044.02%
20131.666.12%
20121.57-19.45%
20111.95-32.94%
20102.90-18.91%
20093.584.86%
20083.41-14.5%
20073.9936.19%
20062.93-44.67%
20055.3035.81%
20043.90-18.84%
20034.8121.21%
20023.974.34%
20013.80

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Novartis
NVS
4.72 79.95%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
2.49-4.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1.84-29.97%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
5.51 110.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
4.26 62.62%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
2.28-13.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
Dr. Reddy's Laboratories
RDY
2.70 2.94%๐Ÿ‡ฎ๐Ÿ‡ณ India